n-methyl-3,4-methylenedioxyamphetamine and concanavalin a

n-methyl-3,4-methylenedioxyamphetamine has been researched along with concanavalin a in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Connor, TJ; Currid, A; Finn, D; Kelly, JP; Leonard, BE; McNamara, MG; O'Malley, M; Redmond, AM1
Connor, TJ; Kelly, JP; Leonard, BE1

Other Studies

2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and concanavalin a

ArticleYear
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat.
    Immunopharmacology, 1998, Volume: 38, Issue:3

    Topics: Animals; Cerebral Cortex; Concanavalin A; Corticosterone; Female; Hallucinogens; Hydroxyindoleacetic Acid; Immunity, Cellular; Leukocyte Count; Lymphocyte Activation; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; T-Lymphocytes; Time Factors

1998
An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats.
    Immunopharmacology, 2000, Volume: 46, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Concanavalin A; Cytokines; Female; Fenfluramine; Immunity; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Agents

2000